Gh Research Plc (GHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GHRS | PHAT | URGN | ||
| Company | Gh Research Plc | Phathom Pharmaceuticals Inc | Urogen Pharma Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.71 | 11.23 | 18.63 | ||
| High | 14.92 | 11.90 | 19.03 | ||
| Low | 13.90 | 11.12 | 17.50 | ||
| Latest | 13.97 | 11.21 | 17.62 | ||
| Change | -0.84 | +0.06 | -0.97 | ||
| % Change | -5.67% | +0.54% | -5.22% | ||
| Volume | 240,000 | 2,623,900 | 975,300 | ||
| 20-Day Average Volume | 234,520 | 1,197,780 | 940,350 | ||
| Previous Close | 14.81 | 11.15 | 18.59 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 15.35 | 11.25 | 19.54 | ||
| 20-Day Raw Stochastic | 2.71% | 27.15% | 2.73% | ||
| 20-Day Relative Strength | 42.89 | 44.27 | 38.93 | ||
| Weighted Alpha | +10.75 | +14.30 | +7.00 | ||
| Today's Opinion | 8% Sell | 72% Sell | 56% Sell | ||
| Previous Opinion | 40% Buy | 72% Sell | 56% Sell | ||
| Last Month's Opinion | 96% Buy | 8% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.56% since 03/13/26 | +8.10% since 03/13/26 | -4.45% since 03/13/26 | ||
| Low | 13.90 on 03/20/26 | 10.33 on 03/16/26 | 17.50 on 03/20/26 | ||
| High | 15.60 on 03/16/26 | 11.90 on 03/20/26 | 19.25 on 03/17/26 | ||
| 1-Month | |||||
| %Chg | -10.42% since 02/20/26 | -1.84% since 02/20/26 | -16.37% since 02/20/26 | ||
| Low | 13.90 on 03/20/26 | 10.02 on 03/12/26 | 17.50 on 03/20/26 | ||
| High | 16.48 on 03/10/26 | 14.39 on 02/26/26 | 21.90 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | +7.79% since 12/19/25 | -36.05% since 12/19/25 | -22.72% since 12/19/25 | ||
| Low | 12.24 on 12/26/25 | 10.02 on 03/12/26 | 17.50 on 03/20/26 | ||
| High | 19.00 on 01/05/26 | 18.31 on 12/23/25 | 24.14 on 12/24/25 | ||
| 6-Month | |||||
| %Chg | +4.80% since 09/19/25 | unch since 09/19/25 | -1.84% since 09/19/25 | ||
| Low | 12.04 on 12/16/25 | 10.02 on 03/12/26 | 15.86 on 10/10/25 | ||
| High | 19.00 on 01/05/26 | 18.31 on 12/23/25 | 30.00 on 11/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 866,545 | 883,337 | 857,777 | ||
| Shares Outstanding, K | 62,029 | 78,799 | 48,682 | ||
| Annual Sales | 0 | 175,110,000 | 109,790,000 | ||
| Annual Net Income | -48,260,000 | -221,250,000 | -153,490,000 | ||
| Last Quarter Sales | 0 | 57,580,000 | 37,840,000 | ||
| Last Quarter Net Income | -14,140,000 | -21,150,000 | -26,360,000 | ||
| 60-Month Beta | 1.00 | 0.51 | 1.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 03/05/26 | -0.08 on 02/26/26 | -0.54 on 03/02/26 | ||
| Latest Earnings Date | 05/14/26 | 05/07/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||